Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

5.72
Delayed Data
As of 3:59pm ET
 -0.34 / -5.61%
Today’s Change
3.61
Today|||52-Week Range
8.37
-6.69%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
AssetsCash0.005.5M119.3M74.1M
 
 
 
 
Short Term Investment Cash-11.3M7.0M53.4M-45.2M
 
 
 
 
 
Cash & Short Term Investments58.8M65.9M119.3M74.1M
 
 
 
 
 
 
ReceivablesReceivables6.9M2.9M109.0K3.5M
 
 
 
 
 
 
InventoriesInventories------0.00--
 
Current AssetsOther Current Assets1.7M1.9M2.5M5.6M
 
 
 
 
 
Current Assets67.5M70.7M121.9M83.3M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross15.7M14.5M12.4M12.7M
 
 
 
 
 
Depreciation-12.3M-12.1M-9.8M-10.3M
 
 
 
 
 
Intangible Assets0.0039.1M36.4M43.9M
 
 
 
 
Other Assets150.0K39.1M36.6M43.9M
 
 
 
 
 
Total Assets76.3M114.5M161.0M131.3M
 
 
 
 
 
 
LiabilitiesAccounts Payable229.0K793.0K1.0M452.0K
 
 
 
 
 
Accrued Expenses3.0M3.6M3.8M7.2M
 
 
 
 
 
Other Current Liabilities4.0M3.7M3.9M7.4M
 
 
 
 
 
Other Liabilities8.7M6.6M6.7M9.7M
 
 
 
 
 
 
Total LiabilitiesDeferred Taxes-2.1M-12.3M-11.3M-11.2M
 
 
 
 
 
Other Liabilities1.1M914.0K17.2M862.0K
 
 
 
 
 
Total Liabilities9.7M35.6M36.1M40.6M
 
 
 
 
 
 
EquityMinority Interest0.000.000.00-7.0K
 
 
Preferred Stock0.000.000.000.00--
Common Equity66.6M79.0M124.9M90.5M
 
 
 
 
 
Total Shareholder Equity66.6M79.0M124.9M90.5M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding46.6M60.8M69.6M69.9M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.